- Home
- RCKT
as 05-09-2025 4:00pm EST
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 764.5M | IPO Year: | N/A |
| Target Price: | $43.90 | AVG Volume (30 days): | 3.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.55 - $26.98 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Rocket Pharmaceuticals Inc. News
RCKT Breaking Stock News: Dive into RCKT Ticker-Specific Updates for Smart Investing
Associated Press Finance
a day ago
Rocket Pharmaceuticals: Q1 Earnings Snapshot
Business Wire
a day ago
Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress
Argus Research
14 days ago
Daily – Vickers Top Buyers & Sellers for 04/25/2025
Simply Wall St.
22 days ago
High Growth Tech Stocks To Watch In The US April 2025
TipRanks
23 days ago
Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz
Simply Wall St.
23 days ago
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?
Argus Research
24 days ago
Daily – Vickers Top Buyers & Sellers for 04/15/2025
Insider Monkey
a month ago
Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple
Compare RCKT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RCKT Rocket Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.